To ask the Minister of State, Foreign, Commonwealth and Development Office, what funding his Department provided for vaccine research and development in each of the last five years; and what he plans to provide in each of the next five years.
Answered on
11 December 2023
Over the last 5 financial years (2018/19 to 2022/23) the Foreign, Commonwealth and Development Office (FCDO) have invested the following amounts in research and development for vaccines to combat diseases of poverty for use in low and lower middle-income countries:
2018/19 | 2019/20 | 2020/21 | 2021/22 | 2022/23 |
£8,528,752 | £29,589,803 | £213,773,395 | £2,391,511 | £13,012,567 |
To date, FCDO has entered into agreements to invest the following amounts on vaccine Research and Development over the next 5 financial years (2023/24 to 2027/28)*:
2023/24 | 2024/25 | 2025/26 | 2026/27 | 2027/28 |
£17,008,587 | £18,626,489 | £17,253,808 | £17,000,000 | £0 |
* The overall investment in vaccine development could increase as a result of a planned funding competition for the research and development of health products to combat diseases of poverty.